Scott Palmer MD, MHS

palmerDirector, DCRI Pulmonary Research

Associate Professor of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine

Scientific Director, DUMC Lung Transplant Program

Associate Director, Duke Clinical Research Training Program

Work: (919) 684-0245


Dr. Palmer will be the PI of the ACC LRRC, overseeing and managing all of the functions of the coordinating center. In his role as PI, Dr. Palmer will interact closely with the other co-investigators to ensure timely and appropriate completion of all aims including effective LRRC communication, grant management and skills development core creation. He will represent the ACC on the LRRC steering committee Dr. Palmer brings unique assets as the ACC PI including successful administrative experience, successful coordination of multicenter research, expertise in NIH peer-review, and in-depth understanding of trainee education.

Dr. Palmer is a clinical pulmonologist whose work emphasizes clinical, translational, and basic science research in human lung transplantation. As a Duke faculty member, he has developed an outstanding and diverse research program in pulmonary disease and transplantation.

Dr. Palmer received his undergraduate education at Oberlin College and attended medical school at Duke University. He continued at Duke for his internship and residency in internal medicine followed by a fellowship in pulmonary and critical care medicine at Duke. In addition, Dr. Palmer has completed advanced training in biostatistics and clinical epidemiology and received a master’s degree in health sciences research from Duke. Dr. Palmer previously served as medical director for Duke’s lung transplant program from 2001–2007. Under his leadership, it grew into one of the most successful transplant programs in the world.

Dr. Palmer has led studies in variety of areas, including depression and quality of life in patients with advanced lung disease, clinical outcomes research in lung transplantation, and prevention of infectious complications in solid organ transplant recipients. He has also led numerous multicenter research projects and completed the only prospective multicenter randomized study of CMV prevention in lung transplantation. In addition, he directs a translational and basic science research laboratory, where investigators are focused on moving novel research ideas from the laboratory bench to the patient bedside. Dr. Palmer’s group was the first to identify an important role for the innate immune system in human transplant rejection. His research has also linked gastroesophageal reflux to allograft dysfunction in lung transplant and has demonstrated that anti-reflux surgery can improve lung function in selected patients. He has also developed two novel mouse models, which are being used to study the mechanisms of transplant-related lung disease. He has demonstrated the ability to successfully move research ideas from bench to bedside and bedside to clinical practice.

Dr. Palmer’s research has been funded by grants from the National Institutes of Health since 2002. He has also received funding from the Cystic Fibrosis Foundation and the Roche Organ Transplant Foundation. Dr. Palmer has authored more than 100 publications, guest-edited two journal issues, serves on the editorial board of the American Journal of Respiratory and Critical Care Medicine, and is an associate editor for the American Journal of Transplantation. He has served in key leadership roles in national and international pulmonary and transplant societies (including serving as past chair for the Clinical Problems Program Committee of the American Thoracic Society and as chair of the American Society of Transplantation Thoracic Community). He has also received numerous honors and awards, including the 2008 American Society of Transplantation Clinical Science Investigator Award.


Skills Development Core Committee

Steering Committee

Administrative Coordinating Center
Principal Investigator